Home/Helus Pharma/Alex Nivorozhkin
AN

Alex Nivorozhkin

Chief Scientific Officer

Helus Pharma

Therapeutic Areas

Helus Pharma Pipeline

DrugIndicationPhase
HLP004Generalized Anxiety Disorder (GAD)Phase 2
CYB004Generalized Anxiety Disorder (GAD)Phase 2